Arvinas, Inc.

ARVN · Healthcare

$9.28

Capitalización: 598.76M USDRendimiento por dividendo: —
Advance¿Es buen momento para comprar Arvinas, Inc.? Pregunta a Copenvest AIObtén una lectura Advance con IA sobre timing, riesgo y qué hacen los inversores rastreados.Preguntar a Copenvest AI

Cargando gráfico…

Noticias

Últimos titulares de esta acción

GlobeNewswire3 sept 2026, 20:01

Arvinas to Participate in Upcoming Investor Conferences

Zacks3 sept 2026, 15:50

Can KT-621 Mark a Turning Point for Kymera Therapeutics?

GlobeNewswire1 sept 2026, 20:01

Arvinas Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires10 ago 2026, 9:40

Morgan Stanley Adjusts Price Target on Arvinas to $10 From $11, Maintains Equalweight Rating

Zacks6 ago 2026, 16:00

Arvinas (ARVN) Upgraded to Strong Buy: Here's What You Should Know